BIOMAT Database Logo BIOMAT Database Logo

[Humoral immunity to herpes simplex virus type 2 in cervical cancer]. 1982

T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva

The analysis of the results of serological studies revealed differences between the number of positively reacting sera from patients with cervical carcinoma and from normal women. The activity of complement-fixing and virus-neutralizing antibodies in the patients' sera and the frequency of their detection were higher than in the sera from normal subjects. These results in combination with other methods of laboratory examinations may be used for early detection of cervical carcinoma as well as for determination of high risk groups with regard to oncological diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002578 Uterine Cervical Dysplasia Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE. Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervix Dysplasia,Dysplasia of Cervix Uteri,Neoplasia, Cervical Intraepithelial,Cervical Intraepithelial Neoplasia, Grade III,Cervical Intraepithelial Neoplasms,Intraepithelial Neoplasia, Cervical,Cervical Dysplasia, Uterine,Cervical Dysplasias,Cervical Intraepithelial Neoplasm,Cervix Uteri Dysplasia,Cervix Uteri Dysplasias,Dysplasia, Cervical,Dysplasia, Cervix,Dysplasia, Uterine Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D005260 Female Females
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Herpes simplex virus type 2 and cervical cancer.
October 1981, Current problems in cancer,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Herpes simplex virus type 2 and cervical cancer.
January 1984, Clinics in dermatology,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Innate immunity to herpes simplex virus type 2.
January 2003, Viral immunology,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
[Humoral immunity to herpes simplex virus in children and adults].
January 1979, Pediatriia,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Herpes simplex type 2 virus and cervical neoplasia.
January 1987, Advances in cancer research,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Cervical carcinogenesis with herpes simplex virus, type 2.
August 1975, Obstetrics and gynecology,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
[Type 2 Herpes simplex virus and cervical carcinoma].
January 1974, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Immunity, herpes simplex virus, and cervical carcinoma.
February 1978, The Surgical clinics of North America,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia.
September 2006, The Journal of infectious diseases,
T A Posevaia, and I F Barinskiĭ, and V V Grigor'ev, and N I Shuvaeva
Herpes simplex virus and human cancer. I. Relationship between human cervical tumours and Herpes simplex type 2.
June 1981, European journal of cancer,
Copied contents to your clipboard!